Frequency of analgesic use and risk of hypertension in younger women

Archives of Internal Medicine

Volumn 162, Issue 19, 2002, Pages 2204-2208

  Curhan, Gary C ^a,b   Willett, Walter C ^a,b   Rosner, Bernard ^a   Stampfer, Meir J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ANALGESIA; ARTICLE; BLOOD PRESSURE REGULATION; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE;

ACETAMINOPHEN; ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 0037190699     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.19.2204     Document Type: Article

References (16)

1. Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA. 2002;287:337-344,
2. Bjorkman DJ. The effect of aspirin and nonsteroidal anti-inflammatory drugs on prostaglandins. Am J Med. 1998;105(suppl 2):8S-12S.
3. Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int. 1987;32:1-12.
4. Amin AR, Attur MG, Pillinger M, Abramson SB, The pleiotropic functions of aspirin: Mechanisms of action. Cell Mol Life Sci. 1999;56:305-312.
5. Ryu YS, Lee JH, Seok JH, et al. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: Differential regulation of NF-κβ by acetaminophen and salicylates. Biochem Biophys Res Commun. 2000;272:758-764.
6. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis [see Comments]. Ann Intern Med. 1994;121:289-300.
7. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994;272:781-786.
8. Pope JE, Anderson JJ, Felson DT, A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993;153:477-484.
9. Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs: A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987;107:628-635.
10. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
11. Rothman KJ. Modern Epidemiology. Boston, Mass: Little Brown & Co Inc; 1986.
12. Mantel N. Chi-square tests with one degree of freedom: Extensions of the MantelHaenszel procedure. J Am Stat Assoc. 1963;58:690-700.
13. Dubach UC, Rosner B, Sturmer T. An epidemiologic study of abuse of analgesic drugs: Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987) [see Comments]. N Engl J Med. 1991;324:155-160.
14. Johnson AG, Nguyen TV, Owe-Young R, Williamson DJ, Day RO. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: The role of endothelin-1. J Hum Hypertens. 1996;10:257-261.
15. Chalmers JP, West MJ, Wing LM, Bune AJ, Graham JR. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. Clin Exp Hypertens A. 1984;6:1077-1093.
16. Clissold SP. Paracetamol and phenacetin. Drugs. 1986;32:46-59.